With a wave of patent expiries washing in, drugmakers are struggling to stay afloat with the difficult and risky core business of drug development (see the April 19, 2011 LRTJ and...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)
+65 6592-6978